A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)

Name: A Study of Evorpacept (ALX148) in Patients With Advanced HER2+ Gastric Cancer (ASPEN-06)
Published: 2022
License: Public Domain

ALX Oncology Inc. · 2022

ClinicalTrials.gov · Datasets · License: Public Domain · 2022

Open Source ↗

gastric-cancer

gastric cancer, gastroesophageal junction adenocarcinoma, gastric adenocarcinoma, alx148, cd47, sirpα, gastric, gastroesophageal, gej, her2 positive, ramucirumab, evorpacept

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 803249
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.